Top Early Stage Digital Health Investors in 2024

Discover the leading players shaping the landscape of Digital Health investment in 2024. In the previous year, the Top Early-Stage Digital Health Investors collectively facilitated a total of 5,884 deals, demonstrating their role in supporting Digital Health ventures. Over the past five years, their combined efforts have fuelled 3,891 deals across a diverse range of 2,463 Digital Health initiatives. Since 2019, 84% of the Top Early-Stage Digital Health Investors prioritized investments in 1,395 ventures headquartered in North America with additional focus directed towards 559 ventures in Europe. Together, the Digital Health ventures backed by these investors have contributed to scientific advancement with 22,402 published research papers, 2,753 regulatory approvals for Digital Health products, and participation in 2,016 clinical trials.